Alkermes Investigational Site

Charlotte, North Carolina 28210

3 studies enrolling now · 8 studies all time

What they study most

Alcohol Dependence, Major Depressive Disorder, Multiple Sclerosis, Narcolepsy Type 1, Narcolepsy Type 2, Relapsing Remitting Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 — Recruiting now
• A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 — Recruiting now
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence — Completed